Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

S. Lok, Anna; Gardiner, David; Lawitz, Eric; Martorell, Claudia; T. Everson, Gregory; Ghalib, Reem; Reindollar, Robert; K. Rustgi, Vinod; McPhee, Fiona; Wind‐Rotolo, Megan; Persson, Anna; Zhu, Kurt; I. Dimitrova, Dessislava; Eley, Timothy; Guo, Tong; M. Grasela, Dennis; Pasquinelli, C

doi:10.1056/nejmoa1104430

Public

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

Published in New England Journal of Medicine • Jan 18, 2012

Authors:

Anna S. Lok

David Gardiner

Eric Lawitz

Abstract

BACKGROUND: Patients with chronic hepatitis C virus (HCV) infection who have not had a response to therapy with peginterferon and ribavirin may benefit from the addition of multiple direct-acting antiviral agents to their treatment regimen. METHODS: This open-label, phase 2a study included an explor...

Subject

Ribavirin

Medicine

Antiviral therapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!